Evidence map›Paper›PMID 37283496›Full record

ArticleBiology of reproduction2023

Basic fibroblast growth factor induces proliferation and collagen production by fibroblasts derived from the bovine corpus luteum†.

Corrine F Monaco, Michele R Plewes, Emilia Przygrodzka, Jitu W George, Fang Qiu, Peng Xiao, Jennifer R Wood, Andrea S Cupp, John S Davis

Open access · hybridAbstract read
In one paragraph

Article in Biology of reproduction, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Unraveling the role of lipid droplets and perilipin 2 in bovine luteal cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Corrine F MonacoDepartment of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.
Michele R PlewesDepartment of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.
Emilia PrzygrodzkaDepartment of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.
Jitu W GeorgeDepartment of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.
Fang QiuDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Peng XiaoDepartment of Genetics, Cell Biology & Anatomy, University of Nebraska Medical Center, Omaha, NE, USA.
Jennifer R WoodDepartment of Animal Science, University of Nebraska-Lincoln, Lincoln, NE, USA.
Andrea S CuppDepartment of Animal Science, University of Nebraska-Lincoln, Lincoln, NE, USA.
John S DavisDepartment of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.
University of Nebraska Medical Center · USUniversity of Nebraska–Lincoln · USUnited States Department of Veterans Affairs · US

Funding

UNMC Structural Biology CoreP20GM103427 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAUL L SORGEN · 2012 to 2026
$59.2M
UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Joann B. Sweasy · 1985 to 2026
$55.0M
Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GUDA, CHITTIBABU · 2016 to 2025
$42.8M
The Aging Pituitary/Gonadal AxisP01AG029531 · NIA · WICHITA STATE UNIVERSITY · PI JOHN S DAVIS · 2009 to 2026
$25.9M
Metabolic Regulators of Corpus Luteum FunctionR01HD092263 · NICHD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DAVIS, JOHN S · 2017 to 2021
$1.6M
Metabolic Events Controlling Ovarian SteroidogenesisR01HD087402 · NICHD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DAVIS, JOHN S · 2017 to 2019
$425k
Vascular remodeling in the ovaryR03HD112585 · NICHD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DAVIS, JOHN S · 2023 to 2023
$154k
Mitochondrial Dynamics and SteroidogenesisIK2BX004911 · VA · OMAHA VA MEDICAL CENTER · PI Michele R Plewes · 2021 to 2026
–
BLRD Research Career Scientist Award ApplicationIK6BX005797 · VA · OMAHA VA MEDICAL CENTER · PI JOHN S DAVIS · 2022 to 2026
–
Signals controlling tissues homeostasis in the ovaryI01BX004272 · VA · OMAHA VA MEDICAL CENTER · PI DAVIS, JOHN S · 2020 to 2023
–
BLRD VA I01 BX004272BLRD VA IK2 BX004911BLRD VA IK6 BX005797NCI NIH HHS P30 CA036727NIA NIH HHS P01 AG029531NICHD NIH HHS R01 HD087402NICHD NIH HHS R01 HD092263NICHD NIH HHS R03 HD112585NIGMS NIH HHS P20 GM103427NIGMS NIH HHS U54 GM115458
6 · The paper itself

Abstract

Cyclic regression of the ovarian corpus luteum, the endocrine gland responsible for progesterone production, involves rapid matrix remodeling. Despite fibroblasts in other systems being known for producing and maintaining extracellular matrix, little is known about fibroblasts in the functional or regressing corpus luteum. Vast transcriptomic changes occur in the regressing corpus luteum, among which are reduced levels of vascular endothelial growth factor A (VEGFA) and increased expression of fibroblast growth factor 2 (FGF2) after 4 and 12 h of induced regression, when progesterone is declining and the microvasculature is destabilizing. We hypothesized that FGF2 activates luteal fibroblasts. Analysis of transcriptomic changes during induced luteal regression revealed elevations in markers of fibroblast activation and fibrosis, including fibroblast activation protein (FAP), serpin family E member 1 (SERPINE1), and secreted phosphoprotein 1 (SPP1). To test our hypothesis, we treated bovine luteal fibroblasts with FGF2 to measure downstream signaling, type 1 collagen production, and proliferation. We observed rapid and robust phosphorylation of various signaling pathways involved in proliferation, such as ERK, AKT, and STAT1. From our longer-term treatments, we determined that FGF2 has a concentration-dependent collagen-inducing effect, and that FGF2 acts as a mitogen for luteal fibroblasts. FGF2-induced proliferation was greatly blunted by inhibition of AKT or STAT1 signaling. Our results suggest that luteal fibroblasts are responsive to factors that are released by the regressing bovine corpus luteum, an insight into the contribution of fibroblasts to the microenvironment in the regressing corpus luteum.

Indexed as

Fibroblast Growth Factor 2ProgesteroneAnimalsCattleCell ProliferationCollagenCorpus LuteumDinoprostFemaleFibroblastsLuteolysisProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor ACollagenDinoprostFibroblast Growth Factor 2ProgesteroneProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor Acorpus luteumfibroblastfibroblast growth factorfibrosisluteolysisPGF2α

Identifiers

PMID37283496
PMCPMC10502575
OpenAlexW4379599237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.